Orthobiologics & Regenerative Medicine Series: A Practical Guide to Doing Research During Residency presented by Y. Fransoua Her, MD, Phd-Stem Cell Ethics

Video Transcription

Video Summary

In the video, Dr. Zubin Master discusses the topic of regenerative medicine and the use of stem cell treatments. He emphasizes the importance of reducing misinformation and providing responsible advancements in the field. Dr. Master explains that there is a rise in the use of stem cell interventions and the need for comprehensive education for physicians and physiatrists. He mentions that the FDA has provided guidelines for the regulation of human cells and tissues products (HCTPs) and explains the distinction between HCTPs that require pre-market review and those that do not. Dr. Master also discusses the prevalence of misinformation and misleading advertising by stem cell clinics, citing examples from patient testimonials and marketing materials. He explains the characteristics of the stem cell industry, including the international market, the potential for physical, emotional, and financial harm, and the rapid growth of clinics offering unproven stem cell interventions. Dr. Master highlights the need for proper patient education, empathetic communication, and responsible counseling for patients considering stem cell treatments. He emphasizes the importance of shared decision-making and providing patients with credible resources and referrals. Dr. Master concludes by discussing the role of Mayo Clinic's Regenerative Medicine Consultation Service and the value of such services in educating patients and addressing their concerns.

Keywords

regenerative medicine

stem cell treatments

misinformation

comprehensive education

FDA guidelines

stem cell clinics

patient testimonials

stem cell industry

patient education

Mayo Clinic